Julia McNabb-Baltar
Brigham and Women's Hospital
40 Papers
186 Citations
Julia McNabb-Baltar is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Pancreatitis. The author has an hindex of 13, co-authored 40 publications. Previous affiliations of Julia McNabb-Baltar include Jewish General Hospital & Johns Hopkins University.
Chat about Author
Papers
Hypertriglyceridemia and acute pancreatitis.
TL;DR: The prompt recognition of hypertriglyceridemia in the setting of acute pancreatitis is essential in both the initial and long-term management of this disease and are essential to prevent recurrent acute pancitis.
210
Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy.
Antoine Duquette,Katel Roddier,Julia McNabb-Baltar,Isabelle Gosselin,Anik St-Denis,Marie-Josée Dicaire,L. Loisel,Damian Labuda,Luc Marchand,Jean Mathieu,Jean-Pierre Bouchard,Bernard Brais +11 more
TL;DR: The study of this large French‐Canadian cohort better defines the phenotype of this ataxia and presents two novel mutations in senataxin including the more common founder mutation in the French‐ Canadian population.
112
Clinical Manifestations of Portal Hypertension
TL;DR: The portal hypertension is responsible for many of the manifestations of liver cirrhosis, including spontaneous bacterial peritonitis, hepatic encephalopathy, cirrhotic cardiomyopathy, hepatopulmonary syndrome, and portopul pulmonary hypertension.
Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis
Mohammad Yaghoobi,Mohammad Yaghoobi,Mohammad Yaghoobi,Sébastien Rolland,Kevin A. Waschke,Julia McNabb-Baltar,Julia McNabb-Baltar,Myriam Martel,Raheleh Bijarchi,P. Szego,Alan N. Barkun +10 more
TL;DR: Despite initial evidence in the literature, nonsteroidal anti‐inflammatory drugs (NSAIDs) have not been widely used to prevent post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP).
75
What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis
TL;DR: Individuals with a first-degree relative affected with Gastric cancer have a risk of about 2.5-fold for the development of gastric cancer, and Screening and preventive strategies should be developed for this high-risk population.
71